RUNX3 and neoplasm: Nonetheless, one probe (cg00117172) mapped in the nonpromoter region of RUNX3 (body gene) was hypermethylated in both comparisons, PDTC/ATC vs NT (Δβ = 0.313) and WDTC-PP vs WDTC-GP (Δβ = 0.102), reinforcing their potential as biomarkers of tumor aggressiveness.